Therapeutic Potential of Axl Blockade in BCR-ABL Negative Myeloproliferative Neoplasms (MPN)

被引：0

作者：

Beitzen-Heineke, Antonia ^{[1
,2
,3
]}

Ben Batalla, Isabel ^{[1
,2
,3
]}

Berenbrok, Nikolaus ^{[1
,2
,3
]}

Paesler, Sarina ^{[1
,2
,3
]}

Gensch, Victoria ^{[1
,2
,3
]}

von Amsberg, Gunhild ^{[1
,2
]}

Schafhausen, Philippe ^{[1
,2
]}

Riecken, Kristoffer ^{[4
]}

Fischer, Thomas ^{[5
]}

Pantel, Klaus ^{[3
]}

Bokemeyer, Carsten ^{[1
,2
]}

Loges, Sonja ^{[1
,2
,3
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf, Univ Comprehens Canc Ctr Hamburg, Hubertus Wald Tumorzentrum, Dept Hematol & Oncol,Sect BMT, Hamburg, Germany

[2] Univ Med Ctr Hamburg Eppendorf, Univ Comprehens Canc Ctr Hamburg, Hubertus Wald Tumorzentrum, Dept Hematol & Oncol,Sect Pneumol, Hamburg, Germany

[3] Univ Med Ctr Hamburg Eppendorf, Ctr Med Expt, Inst Tumor Biol, Hamburg, Germany

[4] Univ Med Ctr Hamburg Eppendorf, Res Dept Cell & Gene Therapy, Dept Stem Cell Transplantat, Hamburg, Germany

[5] Otto Von Guericke Univ, Dept Hematol & Oncol, Magdeburg, Germany

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-118175

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3063

引用

页数：3

共 50 条

[1] Therapeutic potential of Axl blockade in BCR-ABL negative myeloproliferative neoplasms (MPN)
Beitzen-Heineke, A.
Ben Batalla, I
Paesler, S.
Gensch, V
Schafhausen, P.
von Amsberg, G.
Riecken, K.
Fischer, T.
Pantel, K.
Bokemeyer, C.
Loges, S.
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 27 - 27
[2] AXL Inhibition Represents a Novel Therapeutic Approach in BCR-ABL Negative Myeloproliferative Neoplasms
Beitzen-Heineke, Antonia
Berenbrok, Nikolaus
Waizenegger, Jonas
Paesler, Sarina
Gensch, Victoria
Udonta, Florian
Delgado, Maria Elena Vargas
Engelmann, Janik
Hoffmann, Friederike
Schafhausen, Philippe
von Amsberg, Gunhild
Riecken, Kristoffer
Beumer, Niklas
Imbusch, Charles D.
Lorens, James
Fischer, Thomas
Pantel, Klaus
Bokemeyer, Carsten
Ben-Batalla, Isabel
Loges, Sonja
HEMASPHERE, 2021, 5 (09): : E630
[3] BCR-ABL negative myeloproliferative neoplasms
Metzgeroth, G.
Lengfelder, E.
Griesshammer, M.
Reiter, A.
ONKOLOGE, 2012, 18 (12): : 1130 - +
[4] Thiol/Disulfide Balance in Older Patients with BCR-ABL Negative Myeloproliferative Neoplasms
Koyuncu, Mahmut B.
Cavusoglu, Cagatay
Basir, Hakan
Ilgan, Mustafa
Ucar, Mehmet A.
Akdeniz, Aydan
Tombak, Anil
Tiftik, Eyup N.
Temel, Gulhan O.
Neselioglu, Salim
Erel, Ozcan
CLINICAL LABORATORY, 2021, 67 (12) : 2700 - 2706
[5] BCR-ABL-negative myeloproliferative NeoplasienBCR-ABL negative myeloproliferative neoplasms
G. Metzgeroth
E. Lengfelder
M. Griesshammer
A. Reiter
Der Onkologe, 2012, 18 (12): : 1130 - 1138
[6] Screening for signs of portal hypertension by esophagogastroduodenoscopy in patients with BCR-ABL negative myeloproliferative neoplasms
Davidson, Marta
Wong, Florence
Atri, Mostafa
Sibai, Hassan
Maze, Dawn
Cheung, Verna
Callum, Jeannie
Atenafu, Eshetu G.
Gupta, Vikas
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (04) : E88 - E90
[7] Evaluation of hMICL As a Marker Associated with Disease Progression in BCR-ABL Negative Myeloproliferative Neoplasms
Nederby, Line
Larsen, Laura Laine
Hokland, Peter
Roug, Anne Stidsholt
BLOOD, 2012, 120 (21)
[8] Arterial and Venous Thromboembolic Complications in 832 Patients with BCR-ABL -Negative Myeloproliferative Neoplasms
Wille, Kai
Deventer, Eva
Sadjadian, Parvis
Becker, Tatjana
Kolatzki, Vera
Huenerbein, Karlo
Meixner, Raphael
Jimenez-Munoz, Marina
Fuchs, Christiane
Griesshammer, Martin
HAMOSTASEOLOGIE, 2024, 44 (05): : 386 - 392
[9] High rate of secondary primary malignancies in patients with BCR-ABL negative myeloproliferative neoplasms
Wille, K.
Sadjadian, P.
Becker, T.
Horstmann, A.
Kolatzki, V
Griesshammer, M.
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 28 - 28
[10] The immune landscape in BCR-ABL negative myeloproliferative neoplasms: inflammation, infections and opportunities for immunotherapy
Strickland, Marie
Quek, Lynn
Psaila, Bethan
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (05) : 1149 - 1158

← 1 2 3 4 5 →